1. 138 Phase 1 dose-escalation study of STRO-002, an anti-folate receptor alpha (FRα) antibody drug conjugate (ADC), in patients with advanced platinum-resistant/refractory epithelial ovarian cancer (OC). (13th November 2020) Authors: Naumann, R; Braiteh, F; Diaz, J; Hamilton, E; Diab, S; Schilder, R; Moroney, J; Martin, L; Uyar, D; O'Malley, D; Penson, R; DiLea, C; Palumbo, M; DeAlmeida, V; Berman, C; Matheny, S; Molina, A Journal: International journal of gynecological cancer Issue: Volume 30(2020)Supplement 3 Page Start: A61 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Cancer Medicine. Issue 4 (April 1997) Authors: Penson, R Journal: Journal of clinical pathology Issue: Volume 50:Issue 4(1997) Page Start: 357 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Cancer Medicine. Issue 8 (August 1997) Authors: Penson, R Journal: Journal of clinical pathology Issue: Volume 50:Issue 8(1997) Page Start: 709 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗